Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program
June 24 2024 - 6:55AM
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
the patient, today announced that St. Marianna University School of
Medicine Yokohama City Seibu Hospital in Japan has entered into an
agreement to lease and utilize a Senhance® Surgical System in the
Urology and Gastroenterology/General Surgery department.
"We are excited to collaborate with the St. Marianna University
School of Medicine Yokohama City Seibu Hospital to bring our
Senhance Surgical System to this innovative institution," said
Anthony Fernando, President and CEO of Asensus Surgical. "Powered
by our Intelligent Surgical Unit™ with Augmented Intelligence
capabilities, this system represents a leap forward, offering
surgeons unparalleled real-time insights that leverage the
collective expertise from procedures performed around the
world."
“The Senhance System's ability to facilitate a seamless
integration of human skill with clinical intelligence will be
tremendously valuable for our surgeons,” said Dr. Masanori Naito,
M.D.,Ph.D. Hospital Vice Director, Head of Gastroenterological
& General Surgery. “Our hospital seeks to blend scientific
excellence with compassionate, patient-centered care. We look
forward to harnessing its capabilities in our GI/General Surgery
& Urology specialties as we continue pushing the boundaries of
medical innovation.”
The Senhance Surgical System is designed to
increase surgeon control and reduce variability through Augmented
Intelligence and deep learning capabilities.
About St. Marianna University School of
Medicine Yokohama City Seibu Hospital
Our university was founded in 1971 by the devout Catholic Dr.
Kamon Akashi. Then-Pope Paul VI took a great interest in the
university’s establishment and presented the special gift of a
chalice and paten to mark the occasion. Japan’s only medical
university with Christian ideals as its founding ethos, our
university has so far trained nearly 5,000 physicians filled with
the spirit of love and dedicated service. This philosophy—the
Marianna Spirit—is reflected not only in the undergraduate
educational curriculum but also throughout the care offered at our
associated medical facilities and in our specialist postgraduate
education and research. It forms the very foundation of our
outstanding education, which produces individuals who are both
proficient scientists and compassionate physicians. St. Marianna
University School of Medicine Yokohama City Seibu Hospital opened
in 1987 as part of the Yokohama 21st Century Plan. It is a
sophisticated general hospital for the 21st century that actively
incorporates the very latest medical care techniques. It also has a
tertiary emergency care center capable of dealing with all fields
of medicine around the clock.
About Asensus Surgical, Inc.
Asensus Surgical is revolutionizing surgery with the first
intra-operative Augmented Intelligence technology approved for use
in operating rooms around the world. Recognized as an award-winning
leader in digital technology, Asensus is committed to making
surgery more accessible and predictable while delivering
consistently superior outcomes. The Company’s novel approach to
digitizing laparoscopy has led to system placements globally. Led
by engineers, medical professionals, and industry luminaries,
Asensus is powered by human ingenuity and driven by collaboration.
To learn more about Asensus, visit www.asensus.com.
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn:
https://www.linkedin.com/company/asensus-surgical-inc/
X: https://twitter.com/AsensusSurgical
YouTube: https://www.youtube.com/@AsensusSurgical
TikTok:https://www.tiktok.com/@asensus_surgical
Forward-Looking Statements
This press release includes statements relating to the Senhance
Surgical System and St. Marianna University School of Medicine
Yokohama City Seibu Hospital in Japan initiating a program with the
Senhance System. These statements and other statements regarding
our future plans and goals constitute "forward looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, and are
intended to qualify for the safe harbor from liability established
by the Private Securities Litigation Reform Act of 1995. Such
statements are subject to risks and uncertainties that are often
difficult to predict, are beyond our control and which may cause
results to differ materially from expectations and include whether
Asensus Surgical can accelerate the adoption of the Senhance
Surgical System throughout Japan and other key geographies around
the world and whether the Senhance Surgical System will enable St.
Marianna University School of Medicine Yokohama City Seibu Hospital
to offer surgeons unparalleled real-time insights that leverage the
collective expertise from procedures performed around the world.
For a discussion of the risks and uncertainties associated with the
Company’s business, please review our filings with the Securities
and Exchange Commission (SEC), including our Annual Report on Form
10-K for the year ended December 31, 2023, filed with the SEC on
March 22, 2024 and our other filings we make with the SEC. You are
cautioned not to place undue reliance on these forward looking
statements, which are based on our expectations as of the date of
this press release and speak only as of the origination date of
this press release. We undertake no obligation to publicly update
or revise any forward-looking statement, whether as a result of new
information, future events or otherwise.
INVESTOR CONTACT:
Mark Klausner or Mike VallieICR
Westwickeinvest@asensus.com443-213-0499
MEDIA CONTACT:Dan VentrescaMatter
CommunicationsAsensusPR@matternow.com617-874-5488
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/eaeea3b9-0c6e-4d0b-b65d-cf0871c00b0c
Asensus Surgical (AMEX:ASXC)
Historical Stock Chart
From May 2024 to Jun 2024
Asensus Surgical (AMEX:ASXC)
Historical Stock Chart
From Jun 2023 to Jun 2024